<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Reina-Campos M</submitter><funding>NIDDK NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>NCI NIH HHS</funding><funding>NIH HHS</funding><pagination>179-187</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11238873</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>621(7977)</volume><pubmed_abstract>Tissue resident memory CD8&lt;sup>+&lt;/sup> T (T&lt;sub>RM&lt;/sub>) cells offer rapid and long-term protection at sites of reinfection&lt;sup>1&lt;/sup>. Tumour-infiltrating lymphocytes with characteristics of T&lt;sub>RM&lt;/sub> cells maintain enhanced effector functions, predict responses to immunotherapy and accompany better prognoses&lt;sup>2,3&lt;/sup>. Thus, an improved understanding of the metabolic strategies that enable tissue residency by T cells could inform new approaches to empower immune responses in tissues and solid tumours. Here, to systematically define the basis for the metabolic reprogramming supporting T&lt;sub>RM&lt;/sub> cell differentiation, survival and function, we leveraged in vivo functional genomics, untargeted metabolomics and transcriptomics of virus-specific memory CD8&lt;sup>+&lt;/sup> T cell po</pubmed_abstract><journal>Nature</journal><pubmed_title>Metabolic programs of T cell tissue residency empower tumour immunity.</pubmed_title><pmcid>PMC11238873</pmcid><funding_grant_id>P01 AI132122</funding_grant_id><funding_grant_id>P30 DK063720</funding_grant_id><funding_grant_id>R01 HL157710</funding_grant_id><funding_grant_id>R01 AI150282</funding_grant_id><funding_grant_id>S10 OD021815</funding_grant_id><funding_grant_id>R01 AI067545</funding_grant_id><funding_grant_id>P30 CA030199</funding_grant_id><funding_grant_id>R37 AI067545</funding_grant_id><funding_grant_id>R01 CA197363</funding_grant_id><funding_grant_id>R37 AI052116</funding_grant_id><funding_grant_id>P01 HL146358</funding_grant_id><funding_grant_id>P30 CA014195</funding_grant_id><funding_grant_id>R01 CA256133</funding_grant_id><funding_grant_id>S10 OD026929</funding_grant_id><funding_grant_id>R01 AI072117</funding_grant_id><pubmed_authors>Mathews IT</pubmed_authors><pubmed_authors>Sharma S</pubmed_authors><pubmed_authors>Luna V</pubmed_authors><pubmed_authors>Huang H</pubmed_authors><pubmed_authors>Jain M</pubmed_authors><pubmed_authors>Nguyen Q</pubmed_authors><pubmed_authors>Krummel MF</pubmed_authors><pubmed_authors>Goldrath AW</pubmed_authors><pubmed_authors>Chi H</pubmed_authors><pubmed_authors>Kennewick K</pubmed_authors><pubmed_authors>Chang JT</pubmed_authors><pubmed_authors>Vichaidit A</pubmed_authors><pubmed_authors>Boland BS</pubmed_authors><pubmed_authors>Bensinger SJ</pubmed_authors><pubmed_authors>Reina-Campos M</pubmed_authors><pubmed_authors>Heeg M</pubmed_authors><pubmed_authors>Santillano N</pubmed_authors><pubmed_authors>Galletti G</pubmed_authors><pubmed_authors>Hu KH</pubmed_authors><pubmed_authors>Milner JJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Metabolic programs of T cell tissue residency empower tumour immunity.</name><description>Tissue resident memory CD8&lt;sup>+&lt;/sup> T (T&lt;sub>RM&lt;/sub>) cells offer rapid and long-term protection at sites of reinfection&lt;sup>1&lt;/sup>. Tumour-infiltrating lymphocytes with characteristics of T&lt;sub>RM&lt;/sub> cells maintain enhanced effector functions, predict responses to immunotherapy and accompany better prognoses&lt;sup>2,3&lt;/sup>. Thus, an improved understanding of the metabolic strategies that enable tissue residency by T cells could inform new approaches to empower immune responses in tissues and solid tumours. Here, to systematically define the basis for the metabolic reprogramming supporting T&lt;sub>RM&lt;/sub> cell differentiation, survival and function, we leveraged in vivo functional genomics, untargeted metabolomics and transcriptomics of virus-specific memory CD8&lt;sup>+&lt;/sup> T cell po</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Sep</publication><modification>2026-04-08T18:40:26.395Z</modification><creation>2025-04-07T12:06:14.131Z</creation></dates><accession>S-EPMC11238873</accession><cross_references><pubmed>37648857</pubmed><doi>10.1038/s41586-023-06483-w</doi></cross_references></HashMap>